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Abstract 
Sera from 16 echinococcosis patients were analyzed with respect o polyclonal B cell activation and 
autoantibody formation. At least 8 of the sera were from patients who were never in tropical countries 
and therefore their cases were not complicated by other parasitic diseases. In comparison with a group 
of 52 healthy controls, these patients had significant levels of antibodies to DNP and haemocyanin, 
indicators of polyclonal B cell activation. There were also significant differences between control and 
patient groups with respect o antibodies to dsDNA, histones, actin, vimentin, and desmin. This is 
the first report of autoantibodies in echinococcosis. 
Introduction 
Polyclonal B cell activation accompanied by the 
appearance of autoantibodies is a recognized feature 
of several parasitic diseases such as visceral leish- 
maniasis (GALVAO~ASTRO et al., 1984!, Chagas 
disease (SCOTT & SNARY, 1982), and malaria (ADU et 
al., 1982; MORTAZAVI-MILANI et at., 1984). In Chagas 
dsease both humoral and cellular nnmunopathologic- 
al mechanisms have been implicated in the overall 
pathology of the chronic state (SCOTT & SNARY, 
1982). The parasitic factor or factors involved in the 
complex immunopathologies are now under investiga- 
tion in several laboratories. We report here yet 
another parasitic disease, caused by larvae of mem- 
bers of the genus Echinoco<cw,. which is accomp+anied 
F~~.$~lonal B cell actlvauon and autoantlbody 
Materials and Methods 
Patients and controls 
Sera from a total of 16 patients (14 with E.granulosus, 2
with E.muZtiloculuris) were analyzed. There were 7 male and 
9 female patients ranging in age from 12 to 72 years. Of 
these, 8 had never been to the tropics, 2 were Turkish males 
working in Switzerland, and one had visited Tibet. Unfortu- 
nately no records of any possible visits to tropical countries 
were available for the re maining 5 patients. Nevertheless, 
there was no evidence that any patient was suffering from 
any other parasitic or other infectious disease at the time the 
serum samples were collected. All of the patients were 
positive for Epstein-Barr virus (EBV) as determined by viral 
capsid antigen (VCA) and Epstein-Barr nuclear antigen 
(EBNA) titres. The control sera were from a group of 
Caucasian ormal controls (CNC) selected from laboratorv 
personnel including 32 males and’ 20 females ranging in age 
from 20 to 54 vears. Of these. 4were EBV-negative. All were 
healthy at the-time of bleed&g and none had been in tropical 
countries for at least a year before bleeding. 
ELZSA procedure 
The protocol for ELISA tests was modified from that 
described by VAINIO et al. (1983). Microtest plates (A/S 
Nunc, Raskilde, Denmark) were coated with appropriate 
amounts of the purified antigens. Most of the antigens used 
have been described (VAINIO et al., 1983). Dinitropheny- 
lated-bovine serum albumin (DNP-BSA) was prepared in 
our own laboratory and its ELISA readings were compared 
with BSA alone. Haemocyanin was Limulus pol hemus 
haemocyanin (Sigma Chemical Co, St Louis, i&souri 
63178, USA). Appropriate dilutions of sera were incubated 
for 2 hours at 37”, the second antibody was peroxidase- 
labelled goat anti-human Ig (Nordic Immunological Labor- 
atories, Tillburg, The Netherlands). Absorbances (A,& in 
the individual wells were read with an automatic ohotometer 
(Titertec Multiskan, E&b OY, Helsinki, Finland) inter- 
faced with an Apple IIc computer. Data files stored on 
floppy disks we&processed and analyzed statistically using 
our own package of statistical programs. 
Results 
The raw data presented in Table 1 are the mean 
values of A492 (+ SD) of the appropriate serum 
dilutions (alwavs the same dilution for the control and 
patient g&ups j, rounded off to two significant figures. 
Background A 492 has not been subtracted and is also 
shown in Table 1. The background in the absence of 
serum always has a considerably lower A 492 than the 
serum samples but the absolute value is quite high in 
the case of keratin. Although there is a clear trend to 
higher A 492 average values in the patient group, we 
cannot make any judgement concerning quantitative 
differences between control and patient groups with- 
out further statistical analyses. Analysis-using CNC 
standard deviation (SD) units (cf. VAINIO et al.. 1983 
for a similar, but hot >denti&, analysis), ho&ever, 
indicates that the average CNC SD units are all 
greater than zero for the patient series and the average 
values for haemocyanin, dsDNA, histones, actin, 
keratin, laminin, and collagen type I are all greater 
than 1 (Table 1). The SDS for the CNC SD units do 
fluctuate very strongly, however. As we are dealing 
with small samples, we applied the Wilcoxon rank test 
to detect differences between the two groups. We 
ranked both A d0, and CNC SD units from lowest to 
highest and compared the hypotheses that the two 
groups (CNC and patients) were the same or diffe- 
rent. As a measure of the difference we used Z, and 
present the results in Table 2 along with the 
corresponding p-values. Differences between the two 
groups may be seen, with the patient group always 
having higher values (except for ssDNA, tubulin, 
laminin, and collagen type I, where no differences 
were detected). The differences for haemocvanin, 
dsDNA, histone, actin, and vimentin were s&r&cant 
at the ~<0*005 level; that for keratin at the ~cO.01 
level; and those for i)NP and desmin at the p~O.05 
level. The same results were obtained ranking A492 
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Table l-ELISA tests for polyclonal B cell activation and autoantibodies in controls and echinococcosis 
patients 
%F 
Haemocvanin 
dsDNA d 
ssDNA 
Histone 
Actin 
Tubulin 
Desmin 
Vimentin 
Keratin 
Laminin 
Collagen Type 
CNc(Ad’ 
-26 IL *04 
90 + -25 
*99 zk -28 
*75 + .19 
*45 zlz *IO 
.92 k *17 
.57 k *19 
-43 t *14 
.43 f -16 
l-21 f *18 
-38 f .18 
.36 + .13 
1.35 5 -52 *26 + -01 
1.38 + 44 -24 f .Ol 
.88 + *52 ~24 + -03 
*87 +- .30 *15 + .Ol 
1.38 + .59 -19 + .Ol 
.60 XL -19 *14 5 *Ol 
*52 + .18 .15 rk *02 
.56 I! *24 .I7 z!I *Ol 
1.49 31 .42 .60 I!Z *03 
.55 + .52 .15 It .Ol 
.53 k .30 *15 + .Ol 
Patients4 
.77 + 1.19 
1.80 31 2.09 
1.41 31 1.60 
.60 f 2.77 
4.98 I? 2.98 
2.71 + 3.47 
*19 f 1.03 
*60 k 1.28 
*85 + 1.45 
1.51 IL 2.26 
1.12 f 3,55 
1.29 3~ 2.31 
1) Mean A4g2 + SD of the group of 52 Caucasian normal controls (CNC). Background values (in the absence of 
serum) are given in (3) but are not subtracted from (1). 
2) Mean Ada2 + SD of the group of 16 echinococcosis patients. The comment concerning background values given 
under (1) is applicable here as well. 
4) Mean CNC SD units t- SD of the 16 natients; CNC SD units = (mean A,gz patients - mean A~92 CNC)/(SD of 
A492 CW. 
Table 2-Quantitation of the Wilcoxon rank test 
zo (1) p 
2.1687 <0.05 --.- 
~sa;~Acyanin 3.4121 <0*005 
3.36’76 -co*005 
ssDNA 
Histone 
Actin 
*2241 * 
4.4402 <o-o05 
3.8169 <0*005 
Tubulin 
Desmin 
Vimentin 
Keratin 
Laminin 
Collagen type I 
*8458 * 
2.0530 <0.05 
2.8410 <0*005 
2.7181 <O*Ol 
1.1494 * 
1.6988 * 
(1) Z, = U-Un/o where U is the rank value of the 
group of 16 echinococcus patients and UR is the 
expected rank value assuming no difference in A492 
between the CNC and patient groups; u is the 
standard deviation as defined by Wilcoxon. 
(2) p is the probability value (based on the unit normal 
distribution) for the difference hypothesis. 
* means there is no significant difference between the 
two groups. 
and CNC SD units. Correlation coefficients were then 
calculated for patient antibodies in those cases where 
significant differences could be found between the 
CNC and patient groups (Table 3). High correlations 
(p<O*Ol evel) were found for anti-DNP and all other 
antibodies except anti-DNA. Anti-DNA could be 
correlated only with anti-histone at the p<O*Ol level 
and anti&stone only with anti-DNP and anti-DNA. 
All other antibodies correlated with each other and 
with anti-DNP and anti-haemocyanin at the p<O*Ol 
confidence level. 
Discussion 
Little is known concerning immune mechanisms in 
cystic or alveolar echinococcosis and it was quite 
surprising to find evidence for antibodies to DNP and 
haemocyanin, indicators of polyclonal B cell activa- 
tion (GALVAO-CASTRO et al., 1984), in these patients. 
The polyclonal B cell activation could be correlated 
with antibodies to cytoskeletal proteins. Antibodies to 
nuclear antigens (dsDNA and histones) were also 
found but these were not well correlated with 
polyclonal B cell activation. 
Despite the spatial delimitation of the hyatid cyst, 
humoral and cellular immune reactions are associated 
Table 3-Correlation coefficients for & g2 in the group of echinococcosis patients 
Antigen 
DNP 
I-Ia-IrAc yanin 
Histone 
Actin 
Desmin 
Vimentin 
Keratin 
DNP Haemocyanin 
- .794** 
.,gp* 1. 
.608* .535* 
,627** .37a* 
.674** .860** 
.806** .814** 
.712** .818** 
.755** .877** 
dsDNA 
.608* 
.535* 
- 
::i:** 
.584: 
%02* 
,558* 
Histom 
627** 
.378* 
.715** 
.188 
.503** 
.357** 
.297** 
Actin 
.674** 
.860** 
.504* 
.188 
G5** 
.882** 
.909** 
Desmin 
.806** 
.814** 
.584* 
.503* 
.805** 
G2** 
.847** 
Vimentin 
.712** 
.818** 
.602* 
.357 
.882** 
.872** 
G5** 
Keratin 
.755** 
.877** 
.558* 
.297 
.909** 
.a47** 
.895** 
- 
** p<O.Ol 
* p<o.os 
No asterisk indicates p>O.l (no correlation) 
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with such lesions. There is a granulomatous cell 
proliferation with many lymmphocytes, as well as 
eosinophils and mast cells, surrounding the parasitic 
vesicles (WILLIAMS, 1982; VUITTON et al., 1984). At 
the same time there is a suggestion of severe 
impairment of the immune system, at least in alveolar 
echinococcosis. In this disease the percentage and 
absolute number of B cells and total PBL are lower 
than in controls. Furthermore, despite a normal 
percentage of T cells, T cell function is impaired, as 
measured by the leucocyte migration test (VUITTON et 
al., 1984). High levels of serum Ig (VUITTON et al., 
1984) might he one reflection of the polyclonal B cell 
activation we report here. 
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